Understanding how ribosome mutations cause specific health issues in Diamond Blackfan Anemia.
Investigating and targeting the translational landscape of DBA
This study is looking at how changes in certain proteins can cause health issues for people with Diamond Blackfan Anemia, a condition that affects how your body makes blood cells, to help us understand why these changes lead to problems like bone marrow failure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11136935 on NIH RePORTER |
What this research studies
This research investigates how mutations in ribosomal proteins lead to specific health problems in patients with Diamond Blackfan Anemia (DBA), a condition that primarily affects blood cell production. The team will explore the role of translational control and protein synthesis in the hematopoietic system, focusing on how these mutations impact gene expression and contribute to symptoms like bone marrow failure. By examining the connections between ribosomal protein mutations and the resulting cellular dysfunction, the research aims to uncover the mechanisms behind DBA's tissue-specific manifestations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Diamond Blackfan Anemia or related ribosomopathies.
Not a fit: Patients with conditions unrelated to ribosomal dysfunction or those without a diagnosis of Diamond Blackfan Anemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and potential therapies for patients suffering from Diamond Blackfan Anemia.
How similar studies have performed: While ribosomopathies have been studied, this research aims to explore novel aspects of translational control that have not been previously examined in depth.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Barna, Maria — Stanford University
- Study coordinator: Barna, Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.